54 Capital Plans Ethiopian Pharma Factory After DealBy
Ethiopia's $400 million drugs market growing at 25% a year
Foreign private-equity investments are increasing in Ethiopia
54 Capital, a London-based private-equity company, plans to build a new plant for Addis Pharmaceutical Factory within two years after investing $30 million in its seventh deal in Ethiopia, an executive said.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.